Biovie Total Liab vs Non Current Liabilities Total Analysis
BIVI Stock | USD 2.82 0.18 6.00% |
Biovie financial indicator trend analysis is way more than just evaluating Biovie Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biovie Inc is a good investment. Please check the relationship between Biovie Total Liab and its Non Current Liabilities Total accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Total Liab vs Non Current Liabilities Total
Total Liab vs Non Current Liabilities Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biovie Inc Total Liab account and Non Current Liabilities Total. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Biovie's Total Liab and Non Current Liabilities Total is 0.55. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Biovie Inc, assuming nothing else is changed. The correlation between historical values of Biovie's Total Liab and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Biovie Inc are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Total Liab i.e., Biovie's Total Liab and Non Current Liabilities Total go up and down completely randomly.
Correlation Coefficient | 0.55 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Non Current Liabilities Total
Most indicators from Biovie's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biovie Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. As of now, Biovie's Selling General Administrative is increasing as compared to previous years. The Biovie's current Issuance Of Capital Stock is estimated to increase to about 66.9 M, while Enterprise Value Over EBITDA is forecasted to increase to (0.03).
2021 | 2022 | 2024 (projected) | Interest Expense | 2.2M | 4.3M | 1.5M | Depreciation And Amortization | 237.4K | 266.8K | 193.4K |
Biovie fundamental ratios Correlations
Click cells to compare fundamentals
Biovie Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Biovie fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 2.1M | 6.0M | 20.1M | 35.1M | 25.2M | 26.5M | |
Total Current Liabilities | 23.5M | 996.4K | 4.2M | 14.5M | 9.4M | 5.1M | |
Total Stockholder Equity | (21.5M) | 5.1M | 3.7M | 15.3M | 15.5M | 16.3M | |
Net Debt | 873.8K | (4.5M) | (6.4M) | (5.0M) | (17.7M) | (16.8M) | |
Retained Earnings | (41.0M) | (224.9M) | (251.0M) | (301.2M) | (334.2M) | (317.5M) | |
Accounts Payable | 1.3M | 996.4K | 2.4K | 3.5K | 3.6M | 3.8M | |
Cash | 37.2K | 4.5M | 18.6M | 19.5M | 23.8M | 25.0M | |
Cash And Short Term Investments | 37.2K | 4.5M | 18.6M | 33.9M | 23.8M | 25.0M | |
Common Stock Total Equity | 50.7K | 520.0 | 2.2K | 2.5K | 2.2K | 2.1K | |
Liabilities And Stockholders Equity | 2.1M | 6.0M | 20.1M | 35.1M | 25.2M | 26.5M | |
Non Current Liabilities Total | 62.5K | 0.0 | 12.3M | 5.3M | 349.9K | 332.4K | |
Other Stockholder Equity | 19.5M | 229.9M | 254.6M | 316.4M | 349.7M | 367.2M | |
Total Liab | 23.6M | 996.4K | 16.4M | 19.8M | 9.7M | 6.9M | |
Total Current Assets | 413.0K | 4.6M | 18.8M | 34.0M | 24.0M | 25.3M | |
Common Stock | 520.0 | 2.2K | 2.5K | 3.6K | 6.2K | 8.0K | |
Other Current Liab | 21.4M | 996.4K | 4.1M | 5.3M | 3.8K | 3.6K | |
Net Tangible Assets | (23.2M) | 3.6M | 2.5M | 14.4M | 16.5M | 17.3M | |
Common Stock Shares Outstanding | 4.9M | 1.2M | 2.5M | 3.2M | 4.5M | 4.7M | |
Non Current Assets Total | 1.7M | 1.4M | 1.3M | 1.1M | 1.2M | 1.3M | |
Other Current Assets | 375.8K | 187.0K | 275.8K | 102.5K | 204.4K | 163.7K | |
Intangible Assets | 1.3M | 1.1M | 866.5K | 637.1K | 407.7K | 387.3K | |
Net Invested Capital | (20.6M) | 5.1M | 15.8M | 29.7M | 34.1M | 35.8M | |
Net Working Capital | (23.1M) | 3.6M | 14.6M | 19.5M | 22.5M | 23.6M | |
Capital Stock | 520.0 | 2.2K | 2.5K | 3.6K | 3.3K | 3.1K |
Currently Active Assets on Macroaxis
When determining whether Biovie Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biovie's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biovie Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biovie Inc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biovie. If investors know Biovie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.08) | Return On Assets (0.67) | Return On Equity (2.08) |
The market value of Biovie Inc is measured differently than its book value, which is the value of Biovie that is recorded on the company's balance sheet. Investors also form their own opinion of Biovie's value that differs from its market value or its book value, called intrinsic value, which is Biovie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biovie's market value can be influenced by many factors that don't directly affect Biovie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biovie's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biovie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biovie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.